Chlorpropamide is a first-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion, used for type 2 diabetes management, though largely superseded by safer sulfonylureas. Simson Pharma's Chlorpropamide reference standard and impurities support continued compendial QC for legacy formulations.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Chlorpropamide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
